AstraZeneca plc Could Help You Retire Early

Retirement may not be so long away for shareholders in AstraZeneca plc (LON: AZN). Here’s why…

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If, like me, you think that the stock market is looking rather high at the moment and could be due a fall, AstraZeneca (LSE: AZN) (NYSE: AZN.US) could be a great company to add to your portfolio.

The reason is that it has a relatively low beta. Indeed, AstraZeneca’s beta is just 0.8, which means that for every 10% fall in the FTSE 100, AstraZeneca should fall 8% (in theory). This would mean that your potential losses from a ‘correction’, ‘bear market or ‘fall’ (or whatever else you’d like to call a setback in the stock market) could be lessened by investing in AstraZeneca.

Of course, the reverse is also true. For every 10% rise in the stock market, AstraZeneca should only go up by 8% (in theory). However, this reduced overall volatility may be rewarded over the long run via higher demand for shares, meaning AstraZeneca could demand a more generous long term valuation as a result. This would be positive for your retirement plans.

In addition, the vast majority of AstraZeneca’s products are patent protected. This provides the company with a significant amount of protection with regards to its revenue visibility. In other words, AstraZeneca is more likely to meet revenue guidance because demand for its drugs is likely to remain and, since it is currently the only producer of the drugs, its revenue should be relatively easy to predict over the short to medium term.

In times of panic and fear, such stability and visibility are generally sought by investors, making the likes of AstraZeneca popular in downturns. Should the stock market fall, your portfolio may be boosted by the inclusion of AstraZeneca.

Furthermore, AstraZeneca could help retirement come that little bit sooner because it trades on a relatively high free cash flow yield, which provides evidence that shares are good value at current prices. A free cash flow yield of 8.9% is extremely high for a large-cap stock like AstraZeneca and it would be of no great surprise for this to fall in future years, with the share price potentially moving in the opposite direction.

Of course, an upward movement would be great news for investors in the stock and could mean their retirement days come sooner than expected.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Peter owns shares in AstraZeneca.

More on Investing Articles

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

2 dirt-cheap UK growth shares to consider for 2025!

These FTSE 250 and small-cap stocks are on sale today! And Royston Wild thinks investors seeking growth shares should give…

Read more »

Couple working from home while daughter watches video on smartphone with headphones on
Investing Articles

Could this FTSE 250 share bounce back in 2025?

Our writer explains why one FTSE 250 share that has had a bad 2024 could see things continue poorly in…

Read more »

Investing Articles

£5,000 invested in Greggs shares at the start of 2023 is now worth…

Greggs shares have outdone the average returns of the FTSE 250 in the past two years! So how much money…

Read more »

Investing Articles

Here’s why the Rolls-Royce share price climbed 90% in 2024

What can we expect from the Rolls-Royce Holdings share price in 2025? Even more of the same, as the recovery…

Read more »

Investing Articles

Here are my top 3 stock market predictions for 2025

Based on performance this year, Jon Smith pinpoints a few different themes he feels could play out next year in…

Read more »

Investing For Beginners

Never fear! Getting started with passive income is easier than many people think

It’s often best to follow the path of least resistance. Our writer explains why getting a start with passive income…

Read more »

Investing Articles

3 reasons to start a Stocks and Shares ISA in 2025, and they’re not all good ones!

Starting a Stocks and Shares ISA might be one of the best New Year's resolutions an investor can make. But…

Read more »

Investing Articles

Could the TikTok ban send the Scottish Mortgage share price nosediving in 2025?

This investor in Scottish Mortgage wonders whether the looming TikTok ban in the US in January will have much effect…

Read more »